P, K., A, R., B, B., & B, M. (2025). The role of IL-17-related signaling in myelomagenesis, disease prognosis/progression, and therapeutic approach-a scoping review. Clinical and experimental medicine, 25(1), 194. https://doi.org/10.1007/s10238-025-01728-6
Chicago Style (17th ed.) CitationP, Kulig, Rałowiec A, Baumert B, and Machaliński B. "The Role of IL-17-related Signaling in Myelomagenesis, Disease Prognosis/progression, and Therapeutic Approach-a Scoping Review." Clinical and Experimental Medicine 25, no. 1 (2025): 194. https://doi.org/10.1007/s10238-025-01728-6.
MLA (9th ed.) CitationP, Kulig, et al. "The Role of IL-17-related Signaling in Myelomagenesis, Disease Prognosis/progression, and Therapeutic Approach-a Scoping Review." Clinical and Experimental Medicine, vol. 25, no. 1, 2025, p. 194, https://doi.org/10.1007/s10238-025-01728-6.